NFE2L2 and diabetic kidney disease: A previous study revealed that inhibiting AR improved renal function and reduced oxidative stress, inflammation, and fibrosis in rats with DKD by activating the Nrf2 pathway, suppressing the activation of the NF-κB pathway, and inhibiting the NLRP3 inflammasome [124].